- Home
- CTVA vs ALC Comparison
CTVA vs ALC Comparison
Compare CTVA & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTVA | ALC |
|---|---|---|
| Founded | 1802 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Ophthalmic Goods |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7B | 39.0B |
| IPO Year | 2018 | 2002 |
Fundamental Metrics
Financial Performance| Metric | CTVA | ALC |
|---|---|---|
| Price | $76.66 | $81.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 12 |
| Target Price | $80.13 | ★ $89.21 |
| AVG Volume (30 Days) | ★ 3.6M | 1.8M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.94% | 0.26% |
| EPS Growth | ★ 23.08 | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | ★ $17,401,000,000.00 | N/A |
| Revenue This Year | $6.15 | $8.01 |
| Revenue Next Year | $3.15 | $6.43 |
| P/E Ratio | $47.93 | ★ $38.31 |
| Revenue Growth | ★ 2.92 | N/A |
| 52 Week Low | $53.40 | $71.55 |
| 52 Week High | $80.91 | $99.20 |
Technical Indicators
Market Signals| Indicator | CTVA | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 53.83 | 47.00 |
| Support Level | $71.67 | $77.10 |
| Resistance Level | N/A | $81.84 |
| Average True Range (ATR) | 1.53 | 1.64 |
| MACD | -0.28 | -0.20 |
| Stochastic Oscillator | 29.78 | 24.37 |
Price Performance
Historical ComparisonAbout CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.